Bipin Savani is an Oncology physician affiliated with Tennessee Oncology. OpenAlex indexes 939 publications with 27,345 citations (h-index 87); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 5% of Hematology / Oncology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3601 The Vanderbilt Clinic
Nashville, TN 372322637
Telephone
615-936-2000Provider last certified this registry record 23 Mar 2022.
Clinical trials
- Peripheral Stem Cell Transplant in Treating Patients With High-Risk Leukemia
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novartis Pharma AGProgram year20242 payments$15,600openpaymentsdata.cms.gov ↗
- Kite Pharma, Inc.Program year20241 payment
- SANOFI-AVENTIS U.S. LLCProgram year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Standardizing Definitions of Hematopoietic Recovery, Graft Rejection, Graft Failure, Poor Graft Function, and Donor Chimerism in Allogeneic Hematopoietic Cell Transplantation: A Report on Behalf of the American Society for Transplantation and Cellular Therapy
Biology of Blood and Marrow Transplantation
2021 - Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
Biology of Blood and Marrow Transplantation
2020 - Redefining and measuring transplant conditioning intensity in current era: a study in acute myeloid leukemia patients
Bone Marrow Transplantation
2020
Similar KOLs
Other experts from the same institution or the same specialty.
Ian Flinn, MD
Tennessee Oncology
Lester Porter, MD
Tennessee Oncology
Annis Marney, MD, MSCI
Tennessee Oncology
Shakthi Bhaskar, MD
Tennessee Oncology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”